As we learned earlier in the course, psychedelic-assisted therapy in a clinical context is fairly new, having only been heavily studied since the mid 20th century. As psychedelic medicines continue to be legally and scientifically recognized for their therapeutic potential, we need more health professionals trained in this modality to support clients who are seeking out these services. There are many potential pathways to becoming a psychedelic-assisted therapist.
Numinus offers a certification pathway in ketamine-, MDMA-, and psilocybin-assisted therapy. Now that you’ve nearly completed this Introduction to Psychedelics course, you’ve already taken your first steps! On behalf of our whole team, sending a warm congratulations and our sincere wishes that you'll continue learning with us.
To obtain the certification, you will also need to take:
*You can select one, two, or all three medicines to specialize in and work with.
If you’re interested, please visit How to Become a Psychedelic-Assisted Therapist.